摘要
本文报道临床药师参与1例脓毒性休克合并骨髓抑制患者的诊疗过程,结合脓毒性休克患者的特殊病理生理特点,分析了患者的初始用药方案并总结抗菌药物优化使用的经验。通过查阅大量文献资料,参与讨论骨髓抑制治疗方案的制定,对提升白细胞及血小板计数的用药选择、剂量调整提供个体化用药建议,并制定个体化的药学监护计划。通过对该病例的学习和整理,为临床药师参与相关临床实践工作提供参考和借鉴。
This paper introduces the participation of clinical pharmacists in the diagnosis and treatment of a patient with septic shock complicated with myelosuppression. Combined with the special pathophysiological characteristics of septic shock patients, the initial medication plan of the patient is analyzed and the experience of optimal use of antibacterial drugs is summarized. Through consulting a large number of literature and participating in discussing the formulation of myelosuppression treatment plan, this paper provides individualized medication suggestions for drug selection and dosage adjustment for increasing white blood cell and platelet count, and formulates individualized pharmaceutical care plan. The study and summary of this case can provide reference for clinical pharmacists to participate in relevant clinical practice.
作者
邵维莉
李莉霞
Shao Weili;Li Lixia(Department of Pharmacy,Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200092,China;Department of Clinical Pharmacy,Baoshan People’s Hospital of Yunan Province)
出处
《药物流行病学杂志》
CAS
2021年第1期44-47,73,共5页
Chinese Journal of Pharmacoepidemiology
关键词
脓毒性休克
骨髓抑制
药学监护
Septic shock
Myelosuppression
Pharmaceutical care